186 related articles for article (PubMed ID: 16555732)
1. [Human recombinant erythropoietin therapy].
Donato H; Ferro H
Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
[TBL] [Abstract][Full Text] [Related]
2. [Clinical use of erythropoietin].
Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
[TBL] [Abstract][Full Text] [Related]
3. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
Alexander SR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin: an update on the therapeutic use in newborn infants and children.
Donato H
Expert Opin Pharmacother; 2005 May; 6(5):723-34. PubMed ID: 15934899
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants.
Schneider JK; Gardner DK; Cordero L
Pharmacotherapy; 2008 Nov; 28(11):1335-40. PubMed ID: 18956993
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for erythropoietin in neonatal medicine?
Mainie P
Early Hum Dev; 2008 Aug; 84(8):525-32. PubMed ID: 18653293
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
8. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.
Strauss RG
Transfus Med Rev; 2006 Jan; 20(1):34-44. PubMed ID: 16373186
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin in clinical practice: current use, effect on survival, and future directions.
Oster HS; Hoffman M; Prutchi-Sagiv S; Katz O; Neumann D; Mittelman M
Isr Med Assoc J; 2006 Oct; 8(10):703-6. PubMed ID: 17125118
[TBL] [Abstract][Full Text] [Related]
11. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
Adamson JW; Spivak JL
Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765
[TBL] [Abstract][Full Text] [Related]
12. [Use of human recombinant erythropoietin in children with cancer].
Guyot D; Margueritte G
Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and its use in renal failure.
Sulková S; Krajhanzl A
EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
15. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA; Morris CA; Winkelmayer WC; Avorn J
Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of anemia correction by recombinant human erythropoietin in predialysis patients with renal failure.
Sapojnikov M; Veksler A; Yagil Y; Kogan J; Turkot S; Boris G; Oren S
Ren Fail; 2005; 27(2):199-203. PubMed ID: 15807186
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin for HIV-related anemia.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):18-24. PubMed ID: 11365957
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
19. Nonhematologic complications of erythropoietin therapy.
Zhu X; Perazella MA
Semin Dial; 2006; 19(4):279-84. PubMed ID: 16893404
[TBL] [Abstract][Full Text] [Related]
20. Managing erythropoietin hyporesponsiveness.
Kwack C; Balakrishnan VS
Semin Dial; 2006; 19(2):146-51. PubMed ID: 16551293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]